Manufacturer record
Regency Healthcare: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Regency Healthcare (Uttarakhand) was declared Not of Standard Quality in January 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 23RL0230, Fungal Diastase & Pepsin Syrup (NVZYME) (exp Dec 2024). CDL Kolkata (CDSCO lab) found it not of standard quality: Assay of Fungal Diastase. Listed in the January 2024 alert.
Records by type
1 record linked to Regency Healthcare in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Fungal Diastase & Pepsin Syrup (NVZYME) | Batch 23RL0230Mfg Jul 2023 · Exp Dec 2024 | Assay of Fungal DiastaseAssay | CDL KolkataCDSCO lab | Jan 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.